Keloid Cause Found: New Welfare Report
- SEOUL, South Korea (April 30, 2025) — Researchers in South Korea have pinpointed a crucial mechanism behind keloid formation, offering a potential new avenue for treatment.
- Park Ji-woong, a professor of plastic surgery at Boramae Hospital in Seoul, led the research, which focused on the role of "mechanical stimulating delivery" in keloid development.
- The team's inquiry highlighted the ROCK1 protein as a central player in this process.
Keloid Scarring Breakthrough: Researchers Identify Key Mechanism, Potential New Treatment
Table of Contents
- Keloid Scarring Breakthrough: Researchers Identify Key Mechanism, Potential New Treatment
- Keloid Scarring: Your Top Questions Answered
- What are Keloids?
- What Causes Keloid Scars?
- What did the research in Seoul, South Korea, discover about keloid formation?
- What is the role of ROCK1 in keloid progress?
- How can inhibiting ROCK1 possibly treat keloids?
- What were the results of the animal studies using ROCK1 inhibitors?
- Were there any side effects observed in the animal studies?
- How is this research a ‘paradigm shift’ in keloid treatment?
- What are the current treatments for keloids, and what are their limitations?
- What are the key takeaways from this research?
- Where was the study published?
- Which populations are most affected by keloid scarring?
- Can this new approach be applied to other conditions?
- Summary of Key Findings: Old vs. New Approach
SEOUL, South Korea (April 30, 2025) — Researchers in South Korea have pinpointed a crucial mechanism behind keloid formation, offering a potential new avenue for treatment. Keloids, characterized by excessive scar tissue growth after skin injury, affect millions worldwide, especially those with skin of color.
Unlocking the Keloid Code: Mechanical Stimuli and ROCK1
dr. Park Ji-woong, a professor of plastic surgery at Boramae Hospital in Seoul, led the research, which focused on the role of “mechanical stimulating delivery” in keloid development. this process involves the skin sensing external physical irritation and converting it into cellular signals that promote cell growth and fiber tissue formation.
The team’s inquiry highlighted the ROCK1 protein as a central player in this process. According to the study, the expression of ROCK1 protein increases rapidly when fibroid cells from keloid patients are subjected to mechanical stress. This, in turn, leads to excessive cell proliferation and fiber tissue development.
Targeting ROCK1: A Novel Treatment Strategy
the research suggests that inhibiting ROCK1 could offer a new therapeutic approach. Experiments showed that ROCK1 inhibitors suppressed the formation of actin filaments, which constitute the cell skeleton, and significantly reduced the expression of fibrosis-related proteins.
Furthermore, the inhibition of ROCK1 also impacted the YAP/TAZ signaling pathway, known to be involved in cell growth and fibrosis, resulting in reduced collagen production.
Animal Studies Show Promise
Animal studies provided compelling evidence for the effectiveness of ROCK1 inhibitors. In immunodeficiency mice models transplanted with human keloid fibroblasts, the administration of ROCK1 inhibitors led to a meaningful reduction in the size and weight of keloid nodules. Researchers also observed a decrease in inflammatory cells and collagen accumulation within the tissue.
Notably, the study reported no observed side effects or toxicity from the drug, increasing the potential for clinical application.
A Paradigm Shift in Keloid Treatment?
Dr. Park’s research proposes a model where keloid formation follows a “mechanic stimuli → ROCK1 signal activation → mechanoRESPONSE” pathway. This understanding marks a departure from treatments focused solely on alleviating symptoms, suggesting the possibility of addressing the root cause of keloids.
If existing treatment has been limited to relieving symptoms or reducing the size of scars, this study is a completely new strategy that targets the fundamental signaling pathway that induces the occurrence of keloids. It can be widely applied to the treatment of fiber diseases.
Publication and Future Implications
The findings were published in 2025 in the British Journal of Dermatology, a peer-reviewed medical journal.
Understanding Keloids
Keloids arise from an overgrowth of fibrous tissue during the healing process after trauma, surgery, or burns. This condition can significantly impair a patient’s quality of life, causing persistent pain, itching, and restricted movement, going beyond the cosmetic concerns of simple scars.
Current treatments, including steroid injections, surgery, and laser therapy, frequently enough have high recurrence rates, with more than 50% of cases returning.The identification of the ROCK1 pathway offers hope for more effective and targeted therapies in the future.
Keloid Scarring: Your Top Questions Answered
What are Keloids?
Keloids are raised scars that extend beyond teh original injury site. Thay’re caused by an overproduction of collagen during the healing process, leading to an excessive growth of fibrous tissue.They are different from hypertrophic scars, which remain within the boundaries of the original wound.
What Causes Keloid Scars?
Keloids develop after skin injuries such as:
- Surgery
- Piercings and tattoos
- Burns
- Skin trauma
- Chickenpox scars
What did the research in Seoul, South Korea, discover about keloid formation?
Researchers in South Korea identified a crucial mechanism in keloid formation. They discovered that mechanical stimuli (physical irritation to the skin) trigger the ROCK1 protein,leading to excessive cell growth and fiber tissue formation,which causes keloids. This points to a new target for potential treatments.
What is the role of ROCK1 in keloid progress?
The research highlights ROCK1 (Rho-associated kinase 1) as a key player. When fibroid cells from keloid patients are subjected to mechanical stress, the expression of ROCK1 increases rapidly, resulting in excessive cell proliferation and fiber tissue development that characterizes keloids.
How can inhibiting ROCK1 possibly treat keloids?
Inhibiting ROCK1 appears to be a promising therapeutic strategy. By suppressing the formation of actin filaments, which form the cell skeleton, and reducing fibrosis-related proteins, ROCK1 inhibitors can help to reduce the excessive growth of keloid tissue. Moreover,they impacted the YAP/TAZ signaling pathway known to be involved in cell growth and fibrosis,resulting in reduced collagen production.
What were the results of the animal studies using ROCK1 inhibitors?
Animal studies involving immunodeficiency mice transplanted with human keloid fibroblasts showed promising results. The governance of ROCK1 inhibitors led to:
- A reduction in the size and weight of keloid nodules
- A decrease in inflammatory cells within the tissue
- A decrease in collagen accumulation
Were there any side effects observed in the animal studies?
No side effects or toxicity were reported in the animal studies, increasing the potential for clinical submission.
How is this research a ‘paradigm shift’ in keloid treatment?
Currently, treatments focus on alleviating symptoms. Dr. Park’s research identifies a root cause pathway: “mechanic stimuli → ROCK1 signal activation → mechanoRESPONSE.” This suggests the possibility of addressing the fundamental cause of keloid formation, rather than just managing symptoms. It offers hope for more effective and targeted therapies.
What are the current treatments for keloids, and what are their limitations?
Current treatments include:
- Steroid injections
- Surgery
- Laser therapy
These treatments frequently enough have a high recurrence rate, with more than 50% of cases returning.
What are the key takeaways from this research?
The groundbreaking research has identified that keloid formation starts with mechanical stimuli. By targeting the ROCK1 protein, the study opens doors for a potential new treatment approach.This could revolutionize the way keloids are treated.
Where was the study published?
The findings were published in the British Journal of Dermatology in 2025.
Which populations are most affected by keloid scarring?
Keloids affect millions worldwide and are more common in individuals with skin of color.
Can this new approach be applied to other conditions?
Dr. Park stated the new strategy could be widely applied to the treatment of fiber diseases.
Summary of Key Findings: Old vs. New Approach
Here’s a table summarizing the current versus the potential new approach to keloid treatment based on the article:
| Feature | Current Treatments | Potential New Treatment (ROCK1 Inhibitors) |
|---|---|---|
| Focus | Symptom Management | Addressing the Root Cause |
| mechanism | Various – Steroids, Surgery, Laser | Inhibiting ROCK1 protein and the “mechanic stimuli → ROCK1 signal activation → mechanoRESPONSE” pathway |
| Recurrence Rate | High (over 50%) | Potentially Lower (based on animal studies) |
| Target | Reducing the size/alleviating symptoms of existing keloids | Preventing/reducing keloid formation at a cellular level |